Printer Friendly

Liquid chromatographic determination of [B.sub.2] vitamers in human plasma and whole blood.

To the Editor:

Riboflavin (RF; vitamin [B.sub.2]) participates in redox reactions in 2 coenzyme forms, flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) (1). Quantification of these 3 flavins in plasma and erythrocytes is essential for studying vitamin [B.sub.2] metabolism (1,2). We describe here an HPLC method for quantifying these flavins in both matrices.

Riboflavin and FMN sodium salt were from Sigma, FAD disodium salt and acetonitrile were from Merck, and the internal standard galactoflavin was from Merck & Dohme. All chemicals were analytical grade. For quality control, we used 3 ClinChek serum and whole-blood controls (Recipe), reconstituted and stored at -80[degrees]C. Aliquots of aqueous (9 g/L NaCl) flavin stock solutions (50 [micro]mol/L) were stored at -20[degrees]C in the dark. Stock solution concentrations were verified by measurement of absorbances at 450 run (3).

The HPLC system consisted of a Thermoquest SP 8700 X pump, Rheodyne Model 7125 100-[micro]L loop injector, Jasco FP-920 fluorescence detector (excitation, 456 run; emission, 512 run), and Shimadzu Model C-R1B Chromatopac Integrator. A Phenomenex Onyx Monolithic [C.sub.18] column [50 x 4.6 mm (i.d.)] protected by a 2 x 4.6 mm (i.d.) [C.sub.18] precolumn was used at ambient temperature. The mobile phase was a mixture of acetonitrile and 0.15 mol/L potassium phosphate buffer, pH 2.4 (6:94 by volume); the flow rate was 3.0 mL/min. The identities and purities of the flavin peaks were verified against retention times, supplementation with pure material, and fluorescence characteristics (see the file on experimental conditions in the Data Supplement that accompanies the online version of this letter at http: //www.clinchem.org/content/vol52/issue5/).

Venous blood samples from 61 fasting volunteers (35 women and 26 men), ages 24-55 years (median, 26 years), were collected into EDTA Vacutainer Tubes (Becton Dickinson) and immediately placed on ice. Aliquots (50 [micro]L) of whole blood were processed or stored at -80[degrees]C until use. The remaining sample was centrifuged (10 min at 20008 and 4[degrees]C), and 50 [micro]L of plasma was processed or stored at -80[degrees]C. Further sampling and manipulations were performed under subdued lighting.

To prepare the samples for analysis, we vortex-mixed 50 [micro]L of plasma, 50 [micro]L of 25 nmol/L aqueous galactoflavin, and 100 [micro]L of 100 g/L trichloroacetic acid for 2 min in a 1.5-mL polypropylene microcentrifuge tube. After centrifugation (5 min at 20008), the supernatant was decanted into a second tube and neutralized with 20 [micro]L of 2.0 mol/L [K.sub.3]P[O.sub.4] For analysis of whole blood, we used 50 [micro]L of sample, 200 [micro]L of internal standard, and 250 [micro]L of 100 g/L trichloroacetic acid and injected 100 [micro]L of the resulting mixture into the HPLC.

We performed calibration with pooled EDTA-plasma enriched with 10 nmol/L RF, 10 nmol/L FMN, and 60 nmol/L FAD or an individual EDTA-whole blood enriched with 10 nmol/L RF, 20 nmol/L FMN, and 300 nmol/L FAD. Aliquots of these enriched samples were stored at -20[degrees]C until analysis.

We calculated concentrations by the peak-area ratios of each flavin vs the internal standard. The basal flavin contents of the plasma and whole blood used for calibration were determined with the standard-addition method (4) (see the experimental section in the online Data Supplement). We tested linearity at concentrations greater than and less than endogenous vitamer concentrations (see the experimental section in the online Data Supplement).

Chromatograms of a plasma and a whole-blood sample before and after addition of the riboflavin vitamers are shown in Fig. 1. Separation on monolithic porous silica columns allowed a shorter run time without loss of performance. Between-day CVs (n = 30) of the retention times were <4%.

[FIGURE 1 OMITTED]

The limits of detection (signal-to-noise ratio = 5) were 1.0 and 2.3 nmol/L for FAD, 0.3 and 0.8 nmol/L for FMN, and 0.5 and 1.3 nmol/L for RF in plasma and whole blood.

The recovery and precision data for the method are summarized in Table 1 of the online Data Supplement. Within- and between-day CVs were 3%-7% and 6%-10%, respectively. The stability of the vitamers and the effects of hemolysis were checked (5), and the obtained results were in agreement with published results (5). The frequency distributions of the concentrations of the 3 flavins in plasma and whole blood from our volunteers agree with those obtained with capillary electrophoresis (5,6), HPLC (3,7,8), and liquid chromatography-tandem mass spectrometry (9).

In whole blood, the concentrations of FAD and RF were correlated (r = 0.34; P = 0.007), the concentrations of FAD and FMN (r = 0.06; P = 0.63) and of RF and FNN (r = 0.09; P = 0.5) were not (see Fig. 1 in the online Data Supplement).

Our simple and sensitive HPLC method for measuring RF and its coenzyme forms in plasma and whole blood allows use of a 50-[micro]L sample with a single deproteinization step for sample preparation and analysis.

References

(1.) Chastain JL, McCormick DB. Flavin metabolites. In: Muller F, ed. Chemistry and Biochemistry of Flavins. Boca Raton, FL: CRC Press, 1991:195-200.

(2.) Quasim T, McMillan DC, Talwar D, Vasilaki A, Denis SJ, Kinsella J. The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients. Clin Nutr 2005;24:956-60.

(3.) Powers JS, Zimmer J, Meurer K, Manske E, Collins JC, Greene HL. Direct assay of vitamins [B.sub.1], [B.sub.2], and [B.sub.6] in hospitalized patients relationship to level of intake. J Parenter Enteral Nutr 1993;17:315-6.

(4.) Skoog DA, West DM, Holler FJ, eds. Fundamentals of Analytical Chemistry, 7th ed. International Edition. Philadelphia: Saunders College Publishing, 1996:572-5.

(5.) Hustad S, Ueland PM, Schneede J. Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma by capillary electrophoresis and laser-induced fluorescence detection. Clin Chem 1999;45: 862-8.

(6.) Hustad S, McKinley MC, McNulty H, Schneede J, Strain JJ, Scott JM, et al. Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supplementation. Clin Chem 2002;48:1571-7.

(7.) Zempleni J. Determination of riboflavin and flavoccenzymes in human blood plasma by high-performance liquid chromatography. Ann Nutr Metab 1995;39:224-6.

(8.) Capo-chichi CD, Gueant J-L, Feillet F, Namour F, Vidailhet M. Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B 2000; 739:219-24.

(9.) Midttun 0, Hustad S, Solheim E, Schneede J, Ueland PM. Multianalyte quantification of vitamin B6 and [B.sub.2] species in the nanomolar range in human plasma by liquid chromatography-tandem mass spectrometry. Clin Chem 2005; 51:1206-16.

Jean-Yves Hautem [1] Claire Morel [1] Remy Couderc [1] Fathi Moussa [1,2] *

[1] APHP, Hopital Trousseau Service de Biochimie Paris, France

[2] Unite Mixte de Recherche Centre National de la Recherche Scientifique 8612 Faculte de Pharmacie Universite Paris-Sud 11 Chatenay-Malabry, France

* Address correspondence to this author at: UMR CNRS 8612, Faculte de Pharmacie, Universite Paris-Sud 11, 22 Rue J-B C16ment, 922696 Chatenay-Malabry, France. Fax 33-146835409; e-mail fathi.moussq@cep.u-psud.fr.

DOI: 10.1373/clinchem.2005.065920
COPYRIGHT 2006 American Association for Clinical Chemistry, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Letters
Author:Hautem, Jean-Yves; Morel, Claire; Couderc, Remy; Moussa, Fathi
Publication:Clinical Chemistry
Article Type:Letter to the editor
Date:May 1, 2006
Words:1229
Previous Article:Lack of utility of free light chain--specific antibodies in the urine immunofixation test.
Next Article:Correction.
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |